High glucose and insulin promote O-GlcNAc modification of proteins, including alpha-tubulin.
about
Hexosamines, insulin resistance, and the complications of diabetes: current status.The Altered Hepatic Tubulin Code in Alcoholic Liver DiseaseCancer metabolism and elevated O-GlcNAc in oncogenic signalingElevation of Global O-GlcNAc Levels in 3T3-L1 Adipocytes by Selective Inhibition of O-GlcNAcase Does Not Induce Insulin ResistanceInhibition of O-GlcNAcase Using a Potent and Cell-Permeable Inhibitor Does Not Induce Insulin Resistance in 3T3-L1 AdipocytesGlucosamine inhibits angiotensin II-induced cytoplasmic Ca2+ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamineGlucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAcIncreased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucoseO-GlcNAc modification of proteins affects volume regulation in Jurkat cells.The hexosamine signaling pathway: O-GlcNAc cycling in feast or famineO-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stressGlucosamine cardioprotection in perfused rat hearts associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation.The tubulin code: molecular components, readout mechanisms, and functionsO-GlcNAc-mediated interaction between VER2 and TaGRP2 elicits TaVRN1 mRNA accumulation during vernalization in winter wheatAberrant O-GlcNAcylated Proteins: New Perspectives in Breast and Colorectal Cancer.Deficient hippocampal insulin signaling and augmented Tau phosphorylation is related to obesity- and age-induced peripheral insulin resistance: a study in Zucker rats.Muscle-specific overexpression of NCOATGK, splice variant of O-GlcNAcase, induces skeletal muscle atrophy.Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.A role for O-GlcNAcylation in setting circadian clock speedGene regulation by Sp1 and Sp3.Post-translational protein modification by O-linked N-acetyl-glucosamine: its role in mediating the adverse effects of diabetes on the heart.Chronic hyperglicemia and nitric oxide bioavailability play a pivotal role in pro-atherogenic vascular modifications.Retinal O-linked N-acetylglucosamine protein modifications: implications for postnatal retinal vascularization and the pathogenesis of diabetic retinopathy.O-GlcNAc modification in diabetes and Alzheimer's disease.Nucleocytoplasmic human O-GlcNAc transferase is sufficient for O-GlcNAcylation of mitochondrial proteinsProtein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system.Dynamic O-GlcNAcylation and its roles in the cellular stress response and homeostasis.Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity.Increased O-GlcNAc causes disrupted lens fiber cell differentiation and cataracts.Protein O-GlcNAcylation in diabetes and diabetic complications.New insights: A role for O-GlcNAcylation in diabetic complications.Chitooligomer-Immobilized Biointerfaces with Micropatterned Geometries for Unidirectional Alignment of Myoblast Cells.Morphological changes in diabetic kidney are associated with increased O-GlcNAcylation of cytoskeletal proteins including α-actinin 4O-linked beta-N-acetylglucosamine (O-GlcNAc) regulates stress-induced heat shock protein expression in a GSK-3beta-dependent manner.O-GlcNAc protein modification in cancer cells increases in response to glucose deprivation through glycogen degradation.Mechanism, Structure, and Inhibition of O-GlcNAc Processing Enzymes.Proteome analysis of metastatic colorectal cancer cells recognized by the lectin Helix pomatia agglutinin (HPA).Inhibition of phospholipase C-beta1-mediated signaling by O-GlcNAc modification.Protein O-GlcNAcylation: A critical regulator of the cellular response to stress.Insulin activates the rat sterol-regulatory-element-binding protein 1c (SREBP-1c) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y cis-acting elements.
P2860
Q24538581-3FCE5BE6-C70C-49AE-BEEF-3C25ADF32BE9Q26782191-68A40CE6-A664-476C-8A77-AD92A1F81424Q26859087-7E04C7DD-ECEF-442A-890D-96476322FB4BQ27652457-F96DEFCD-2F23-4370-9C14-1E6ACCA8B9F8Q27664569-BAD005C7-7FD3-4B1E-A1B3-E2FD450CFB21Q28565649-016930DB-5EEF-4DB5-8E31-9F541F72A079Q28571555-A7BC5859-9D49-429D-88D8-C6B8CAAF1A3FQ28573520-8A40D15D-1E6D-444C-8805-1129A935DC2BQ33521462-A4D15113-352A-4808-9324-3EC751076E78Q33625053-4E5FC062-4CDC-442A-885F-DCF7E1B78B1CQ33625265-F7C1D66D-A722-42AD-BA82-872710B4F60DQ33772151-46BA6A71-4C14-4570-81DE-41F8641F6C8FQ34062557-8C154620-B665-4126-9983-0B8C656F626DQ34086378-F9799071-A93B-4F4E-BDE2-723B6DED3A8EQ34488445-4453CA8A-1F0D-44F8-A41F-CD31DD2836F0Q34667762-1F61F1D6-E8AD-452D-9D75-8C2263C4DE04Q34718031-D473CB46-3786-4D20-BD5F-25028D35197FQ35804446-F5C6035A-D0B8-4746-B436-9F997C299B38Q35835224-3EDADC86-ED1E-4CD1-B2E6-18837429C2C2Q35851299-45C7CF92-65DC-41F4-8F15-3BB31710572CQ36484390-0BD1D895-B3B9-40C5-ACD5-8DD6C42BC3DEQ36776710-EB4CD873-DF7B-4FEC-B4B8-C452BFBDC4ABQ36890350-A1A68263-3102-4878-88DB-DA81FB3973DAQ36973321-6103663A-EC7E-44FD-AFDD-8F0D8296ECCEQ36990867-83EA676B-EAD7-4B17-AA2A-EA09D2463AF2Q37088282-BC120337-9D7A-4B92-B18B-A689404320BEQ37099485-9D48A45E-CEEB-42B0-B70C-5FCD48B1D622Q37114599-CF0EE6AD-9117-421D-B076-4CCDAA6B5FF0Q37330282-A70A0FEF-078A-45BB-BA47-2DC1BA34059FQ38132916-C99E47D5-1A19-4816-8BC7-5A21EC1A4CC2Q38710250-56BDF05A-450E-4CD6-B671-26666EC70FA8Q38801791-8A3817BA-7732-4FF3-A79E-E71431F9F2B2Q39389727-376881A4-8DAE-4F6A-91E7-7BE3B28F34F3Q39647598-841CAFF8-B09A-4CEE-88F7-840028007C5EQ39786978-28291531-B563-4F06-B0B0-E91BABFA6E5EQ40025244-3AF1230C-7124-43E2-BBE2-27F8B4F4CCB0Q40053811-116DA12B-F22B-47BB-B555-692240D7A2F5Q40304681-0483B5AD-5A88-4BF4-A6EE-EEB3C7A1248FQ40794510-59045FEF-8C8D-43D7-90B2-5584536B38BCQ42053294-7BF0EAA1-3AB9-47E8-9AA2-D95637D0BCA0
P2860
High glucose and insulin promote O-GlcNAc modification of proteins, including alpha-tubulin.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
High glucose and insulin promo ...... eins, including alpha-tubulin.
@en
High glucose and insulin promo ...... eins, including alpha-tubulin.
@nl
type
label
High glucose and insulin promo ...... eins, including alpha-tubulin.
@en
High glucose and insulin promo ...... eins, including alpha-tubulin.
@nl
prefLabel
High glucose and insulin promo ...... eins, including alpha-tubulin.
@en
High glucose and insulin promo ...... eins, including alpha-tubulin.
@nl
P2093
P2860
P1476
High glucose and insulin promo ...... eins, including alpha-tubulin.
@en
P2093
Jennie L E Walgren
Kevin L Schey
Maria G Buse
Timothy S Vincent
P2860
P304
P356
10.1152/AJPENDO.00382.2002
P577
2002-10-22T00:00:00Z